Ashlyn Bassiri, PhD
Vice President, Immunology
Ashlyn Bassiri is the Vice President of Immunology at Kriya Therapeutics. Previously, Dr. Bassiri was the Head of Translational Safety at CSL Behring. Prior to this, she was the Pharmacovigilance Leader for all liver-targeted programs at Spark Therapeutics, and supported the US and European filings for LUXTURNA®. She spent ten years in R&D at GlaxoSmithKline where she focused on immune toxicities in both the nonclinical and clinical safety groups, eventually chairing the Immune Safety panel.
Dr. Bassiri received her PhD in Immunology from the University of Pennsylvania School of Medicine, and her master’s and undergraduate degrees in Biomedical Sciences and Immunology from Ohio University.